These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7558013)

  • 1. Assignment of human alpha-synuclein (SNCA) and beta-synuclein (SNCB) genes to chromosomes 4q21 and 5q35.
    Spillantini MG; Divane A; Goedert M
    Genomics; 1995 May; 27(2):379-81. PubMed ID: 7558013
    [No Abstract]   [Full Text] [Related]  

  • 2. Genomic organization and expression of the human beta-synuclein gene (SNCB).
    Lavedan C; Leroy E; Torres R; Dehejia A; Dutra A; Buchholtz S; Nussbaum RL; Polymeropoulos MH
    Genomics; 1998 Nov; 54(1):173-5. PubMed ID: 9806846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-resolution mapping of SNCA encoding alpha-synuclein, the non-A beta component of Alzheimer's disease amyloid precursor, to human chromosome 4q21.3-->q22 by fluorescence in situ hybridization.
    Shibasaki Y; Baillie DA; St Clair D; Brookes AJ
    Cytogenet Cell Genet; 1995; 71(1):54-5. PubMed ID: 7606927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The human NACP/alpha-synuclein gene: chromosome assignment to 4q21.3-q22 and TaqI RFLP analysis.
    Chen X; de Silva HA; Pettenati MJ; Rao PN; St George-Hyslop P; Roses AD; Xia Y; Horsburgh K; Uéda K; Saitoh T
    Genomics; 1995 Mar; 26(2):425-7. PubMed ID: 7601479
    [No Abstract]   [Full Text] [Related]  

  • 5. Synucleins are expressed in the majority of breast and ovarian carcinomas and in preneoplastic lesions of the ovary.
    Bruening W; Giasson BI; Klein-Szanto AJ; Lee VM; Trojanowski JQ; Godwin AK
    Cancer; 2000 May; 88(9):2154-63. PubMed ID: 10813729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synphilin-1 associates with alpha-synuclein and promotes the formation of cytosolic inclusions.
    Engelender S; Kaminsky Z; Guo X; Sharp AH; Amaravi RK; Kleiderlein JJ; Margolis RL; Troncoso JC; Lanahan AA; Worley PF; Dawson VL; Dawson TM; Ross CA
    Nat Genet; 1999 May; 22(1):110-4. PubMed ID: 10319874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exacerbated synucleinopathy in mice expressing A53T SNCA on a Snca null background.
    Cabin DE; Gispert-Sanchez S; Murphy D; Auburger G; Myers RR; Nussbaum RL
    Neurobiol Aging; 2005 Jan; 26(1):25-35. PubMed ID: 15585343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. alpha-Synuclein gene and Parkinson's disease. The French Parkinson's Disease Study Group.
    Science; 1998 Feb; 279(5354):1116-7. PubMed ID: 9508681
    [No Abstract]   [Full Text] [Related]  

  • 9. Deletion of multimerin-1 in alpha-synuclein-deficient mice.
    Specht CG; Schoepfer R
    Genomics; 2004 Jun; 83(6):1176-8. PubMed ID: 15177571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene dosage and pathogenesis of Parkinson's disease.
    Eriksen JL; Przedborski S; Petrucelli L
    Trends Mol Med; 2005 Mar; 11(3):91-6. PubMed ID: 15760766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuronal and glial accumulation of alpha- and beta-synucleins in human lipidoses.
    Suzuki K; Iseki E; Togo T; Yamaguchi A; Katsuse O; Katsuyama K; Kanzaki S; Shiozaki K; Kawanishi C; Yamashita S; Tanaka Y; Yamanaka S; Hirayasu Y
    Acta Neuropathol; 2007 Nov; 114(5):481-9. PubMed ID: 17653558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developmental loss and resistance to MPTP toxicity of dopaminergic neurones in substantia nigra pars compacta of gamma-synuclein, alpha-synuclein and double alpha/gamma-synuclein null mutant mice.
    Robertson DC; Schmidt O; Ninkina N; Jones PA; Sharkey J; Buchman VL
    J Neurochem; 2004 Jun; 89(5):1126-36. PubMed ID: 15147505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of alpha-, beta-, and gamma-synuclein in glial tumors and medulloblastomas.
    Fung KM; Rorke LB; Giasson B; Lee VM; Trojanowski JQ
    Acta Neuropathol; 2003 Aug; 106(2):167-75. PubMed ID: 12783249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parkinson's disease is not associated with the combined alpha-synuclein/apolipoprotein E susceptibility genotype.
    Khan N; Graham E; Dixon P; Morris C; Mander A; Clayton D; Vaughan J; Quinn N; Lees A; Daniel S; Wood N; de Silva R
    Ann Neurol; 2001 May; 49(5):665-8. PubMed ID: 11357958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced neuritic outgrowth and cell adhesion in neuronal cells transfected with human alpha-synuclein.
    Takenouchi T; Hashimoto M; Hsu LJ; Mackowski B; Rockenstein E; Mallory M; Masliah E
    Mol Cell Neurosci; 2001 Jan; 17(1):141-50. PubMed ID: 11161475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From genetics to pathology: tau and alpha-synuclein assemblies in neurodegenerative diseases.
    Goedert M; Spillantini MG; Serpell LC; Berriman J; Smith MJ; Jakes R; Crowther RA
    Philos Trans R Soc Lond B Biol Sci; 2001 Feb; 356(1406):213-27. PubMed ID: 11260802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synucleins and their relationship to Parkinson's disease.
    von Bohlen Und Halbach O
    Cell Tissue Res; 2004 Oct; 318(1):163-74. PubMed ID: 15503152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trypsin disrupts the trafficking of the human dopamine transporter by alpha-synuclein and its A30P mutant.
    Wersinger C; Vernier P; Sidhu A
    Biochemistry; 2004 Feb; 43(5):1242-53. PubMed ID: 14756560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expression of alpha-, beta-, and gamma-synucleins in olfactory mucosa from patients with and without neurodegenerative diseases.
    Duda JE; Shah U; Arnold SE; Lee VM; Trojanowski JQ
    Exp Neurol; 1999 Dec; 160(2):515-22. PubMed ID: 10619569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-synuclein exhibits chaperone activity more efficiently than alpha-synuclein.
    Lee D; Paik SR; Choi KY
    FEBS Lett; 2004 Oct; 576(1-2):256-60. PubMed ID: 15474047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.